Idera Pharma downgraded by Wedbush with a new price target

3/19/21 8:07:41 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Wedbush downgraded Idera Pharma from Outperform to Neutral and set a new price target of $1.00 from $8.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IDRA

Date	Price Target	Rating	Analyst